AI assistant
Sending…
Tvardi Therapeutics, Inc. — Director's Dealing 2021
Nov 17, 2021
9999_dirs_2021-11-16_2b29ca8a-c595-4960-bc46-425e63ddae6d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Cara Therapeutics, Inc. (CARA)
CIK: 0001346830
Period of Report: 2021-11-12
Reporting Person: Ives Jeffrey L. (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-11-12 | Common Stock | S | 8180 | $16.04 | Disposed | 7200 | Direct |
More from Tvardi Therapeutics, Inc.
Interim / Quarterly Report
2026
May 8
Earnings Release
2026
May 8
Regulatory Filings
2026
Apr 1
Annual Report
2026
Apr 1
Director's Dealing
2026
Feb 2
Director's Dealing
2026
Feb 2
Director's Dealing
2026
Feb 2
Director's Dealing
2026
Feb 2
Investor Presentation
2026
Jan 16
Board/Management Information
2025
Dec 18